British Pound: Neutral stance against US Dollar with carry support – OCBC
OCBC strategists Sim Moh Siong and Christopher Wong highlight that the Pound (GBP) remains resilient to local political developments and fiscal risks, supported by foreign inflows into gilts and the Bank of England’s (BoE) reluctance to ease policy amid resilient growth and disinflation. Attention turns to Andy Burnham’s choice of Chancellor and fiscal approach, with markets focused on Autumn Budget execution. They maintain a neutral view on GBP and a broadly flat EUR/GBP profile.
Carry and policy keep Pound supported
"GBP stays supported by carry and steady growth. Fiscal clarity from the incoming leadership is key. Markets want delivery at the Autumn Budget. For now, we remain neutral with EUR/GBP broadly range-bound."
"The GBP has proven resilient to local political developments and associated fiscal risks. Carry support from foreign inflows into gilts should be in place for longer, as the BoE remains reluctant to ease policy amid resilient growth – even with ongoing disinflation."
"Attention now turns to prime ministerial candidate Andy Burnham’s choice of Chancellor and fiscal approach. Early signals suggest continuity with the current fiscal framework, but markets will place greater weight on execution at the Autumn Budget than on early guidance."
"In Manchester, Burnham pledged to stick to existing fiscal rules while prioritising re-industrialisation and devolution. We maintain a neutral view on GBP, reflected in a broadly flat EUR/GBP profile."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
